6-ethoxynicotinaldehyde, 95.0%, 25g

3-(Dibenzylamino)-2,2-difluoropropanoic acid, 97%, 250mg

5-Bromo-2-(4-methoxyphenyl)pyridine, 95+%, 500mg

N-(4-(Hydroxymethyl)phenyl)methanesulfonamide, 96%, 100mg

Nazartinib, 100mg

Methyl 6-O-(N-heptylcarbamoyl)-a-D-glucopyranoside, 99.0%, 1g

4-Amino-2,6-difluorophenol hydrochloride, 95.0%, 1g

1-Fluoro-3-(2-methoxyethoxy)-2-nitrobenzene, 95.0%, 10g

1-(Pentafluoroethyl)-4-propyl-benzene, 1g

5-Amino-2,N,N-trimethyl-benzenesulfonamide, 1g

2.68M HCl in 1,4-Dioxane (HCl 10% w/w), 100ml

(R)-2-(4-Benzylpiperazin-2-yl)acetonitrile, 98%, 250mg

(R)-(2-Methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-yl)methanol, 97%, 5g